Smith & Nephew PLC — Director's Dealing 2024

May 21, 2024

National Storage Mechanism | Additional information

RNS Number : 2832P

Smith & Nephew Plc

21 May 2024

SMITH & NEPHEW PLC

21 May 2024

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

1.   VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020

On 20 May 2024, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.

i. PARTIAL VESTING OF CONDITIONAL SHARE AWARD GRANTED ON 12 AUGUST 2022

The awards were granted under the Global Share Plan 2020 on 12 August 2022. One third of the Shares vested on 20 May 2023, a further third vested on 20 May 2024 and the final third will vest on 20 May 2025. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.

The following relates to the individual included in the below notification:

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code	ISIN: GB0009223206
Nature of the transaction	Partial vesting of Conditional Share Awards granted on 12 August 2022 under the Smith & Nephew Global Share Plan 2020.
Date of Transaction	2024 - 05 - 20
Place of Transaction	London Stock Exchange (XLON)

Name (Position)	Status	Price (£)	Volume	Aggregated information
Vasant Padmanabhan (President Research & Development ENT)	PDMR	10.290135	9,813 (of which 3,130 were sold and 6,683 retained.)	N/A Single Transaction

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

Tel:  +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFIFETELILFIS